Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SUN11031
- Development stage
- Phase 2
- Lead developer
- Oxeia Biopharmaceuticals
- Modality
- Peptides, Small Molecules
- Administration
- Subcutaneous
01
Overview
SUN11031 is a fully synthetic analog of the human ghrelin hormone. It was originally developed for the treatment of muscle wasting (cachexia) and appetite disorders associated with chronic diseases such as chronic obstructive pulmonary disease (COPD). More recently, it has been acquired by Oxeia Biopharmaceuticals and is being developed under the code name OXE-103 for the treatment of concussion and other acute neurotrauma. Ghrelin is a peptide hormone known for its pleiotropic neuroprotective properties, including effects on appetite regulation, muscle mass preservation, and potential benefits in brain injury recovery. SUN11031 has demonstrated a strong safety profile across nine clinical studies involving 345 patients[2][3][9].
- Other names
- Synthetic Human Ghrelin
02
Targets
GHSR (Growth hormone secretagogue receptor)
Beyond the preview
Go deeper on SUN11031.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SUN11031.